Drug Discovery & Development

Strategies & Technologies Driving Drug Discovery to Market

Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Digestions System

March 9, 2009 9:16 am | Product Releases | Comments

SCP SCIENCE expanded their DigiPREP Digestion Systems product line to include three new products.

Obama Overturns Bush Policy On Stem Cells

March 9, 2009 8:28 am | by Philip Elliott, Associated Press Writer | News | Comments

President Barack Obama said he is allowing federal taxpayer dollars to fund significantly broader research on embryonic stem cells.

TOPICS:

Cranberry Products Prevent Urinary Tract Infections

March 9, 2009 7:48 am | News | Comments

Chemicals present in cranberries prevent infection-causing bacteria from attaching to the cells that line the urinary tract.

TOPICS:
Advertisement

Tetralogic Pharmaceuticals Licenses Exclusive Rights to Novel Necrosis Inhibitors

March 9, 2009 7:36 am | News | Comments

TetraLogic Pharmaceuticals announced that they executed a license agreement under which they acquired exclusive worldwide rights from Harvard University to commercialize novel necrostatin compounds and related drug discovery technology developed at Harvard Medical School.

TOPICS:

Accelerating Use of Genomics Research for Medical Applications

March 9, 2009 7:14 am | News | Comments

Applied Biosystems and the Translational Genomics Research Institute announced a strategic alliance designed to accelerate research into complex diseases and medical conditions.

TOPICS:

Drug-Free Remission for HIV Infection

March 9, 2009 6:52 am | News | Comments

A group of academic and industry scientists has issued a challenge to researchers in the field of HIV/AIDS: find a way to effectively purge latent HIV infection and eliminate the need for chronic, suppressive therapy to control this disease.

TOPICS:

Packaging Solutions for Pharmaceutical Unit Dose

March 9, 2009 6:30 am | Product Releases | Comments

PTI Packaging Systems announced Toyo Machine Manufacturing will exhibit stick packaging machinery at Interphex 2009.

TOPICS:

Secure Implementation of RFID in the Pharmaceutical Supply Chain

March 9, 2009 6:08 am | News | Comments

Members of the RFID Security Alliance (RFIDSA) are participating in a panel discussion at the 2009 INTERPHEX conference titled ‘Securely Implementing RFID in the Pharmaceutical Supply Chain.’

TOPICS:
Advertisement

Peristaltic Technology

March 9, 2009 5:54 am | Product Releases | Comments

Watson-Marlow’s peristaltic technology simplifies cleaning validation and enhances the integrity of high purity upstream processes, purification, and fill/finish applications.

Dissolution Imager

March 9, 2009 5:36 am | Product Releases | Comments

Using the ActiPix Dissolution Imager from Paraytec, formulation scientists are able 'to see' in real-time what is happening at a tablet surface during the process of dissolution.

TOPICS:

cHiPLC-nanoflex System

March 9, 2009 5:24 am | Product Releases | Comments

Eksigent introduced the cHiPLC-nanoflex System, delivering improved reproducibility and ease of use to proteomics research.

TOPICS:

Mass Spectrometer

March 9, 2009 5:16 am | Product Releases | Comments

The AccuTOF-GCv mass spectrometer from JEOL features high sensitivity.

TOPICS:

Multiplex Array Instrument

March 9, 2009 5:04 am | Product Releases | Comments

BiOptix announced its four feature true multiplex array instrument with anticipated ship dates in the third quarter of 2009.

TOPICS:

Merck Buying Schering-Plough In A $41.1B Deal

March 9, 2009 4:40 am | by Linda Johnson, AP Business Writer | News | Comments

Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in stock and cash in a deal that gives the companies more firepower to compete in a drug industry facing slumping sales, tough generic competition, and intense cost pressures.

TOPICS:

Obama To Reverse Limits On Stem Cell Work

March 6, 2009 12:12 pm | by Ben Feller and Lauran Neergaard, Associated Press Writers | News | Comments

President Barack Obama is expected to sign an executive order on Monday reversing restrictions on federal funding of embryonic stem cell research.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading